药事管理与临床药学系崔一民团队和药物化学系刘振明团队发现靶向整合素受体的前列腺癌潜在新疗法
北京大学药学院
The teams of Prof. Yimin Cui and Prof. Zhenming Liu have discovered a potential new treatment for castration-resistant prostate cancer that targets integrin receptors
School of Pharmaceutical Sciences, Peking University Health Science Center
中国药学(英文版)
.
2023, (2): 158
-161
.
>
>